Pulmonx Corporation (LUNG)
NASDAQ: LUNG · IEX Real-Time Price · USD
7.28
-0.02 (-0.27%)
Apr 26, 2024, 4:00 PM EDT - Market closed
Pulmonx Revenue
In the year 2023, Pulmonx had annual revenue of $68.68M with 27.98% growth. Revenue in the quarter ending December 31, 2023 was $19.28M with 24.98% year-over-year growth.
Revenue (ttm)
$68.68M
Revenue Growth
+27.98%
P/S Ratio
4.09
Revenue / Employee
$246,147
Employees
279
Market Cap
280.55M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 68.68M | 15.01M | 27.98% |
Dec 31, 2022 | 53.66M | 5.25M | 10.84% |
Dec 31, 2021 | 48.42M | 15.68M | 47.91% |
Dec 31, 2020 | 32.73M | 138.00K | 0.42% |
Dec 31, 2019 | 32.60M | 12.59M | 62.94% |
Dec 31, 2018 | 20.00M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Akebia Therapeutics | 194.62M |
Sanara MedTech | 64.99M |
Metagenomi | 44.76M |
TriSalus Life Sciences | 18.51M |
Lyra Therapeutics | 1.56M |
LUNG News
- 16 days ago - Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024 - GlobeNewsWire
- 24 days ago - Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer - GlobeNewsWire
- 6 weeks ago - Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial - Business Wire
- 2 months ago - Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 2 months ago - Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer - GlobeNewsWire
- 2 months ago - Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024 - GlobeNewsWire
- 5 months ago - Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference - GlobeNewsWire